timetable
TRANSCRIPT
e58 9
Room 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00
Room 1 301Symposium 1 (S1)
Toxico-epigenomics learned from a viewpoint of developmental biology and congenital anomaly 2.0
9:20 ~ 11:20
Educational Lecture 1(EL1)Immune-enhancing adjuvant for
development of safe vaccines
Tsukasa SEYA11:30 ~ 12:30
Luncheon Seminar (L1-1)SEKISUI MEDICAL CO., LTD.
12:40 ~ 13:40
Special Lecture 2 (SL2)Toward the Mysteries of Sleep
Masashi YANAGISAWA13:50 ~ 14:50
Room 2 401
CM1-
2A
Symposium 2 (S2)JALAS-JSOT Joint Symposium
9:20 ~ 11:20
Oral Session 1 (O-1 ~ O-5)
11:30 ~ 12:30
CM1-
2B
Symposium 7 (S7)Species differences and prediction of human responses withbiotherapeutics: review the monkey as a laboratory animal
14:50 ~ 16:50
Room 3 402
CM1-
3A
Symposium 3 (S3)New trends in genotoxicity research involving genome instability
9:20 ~ 11:50
Symposium 8 (S8)Risk assessments for drug-induced convulsions
14:50 ~ 16:50
Room 4 403Symposium 4 (S4)
Chemical sensing transcription factors: Toward understanding toxicity mechanism and risk assessment
9:20 ~ 11:20
Symposium 9 (S9)ToxicOmic AI analysis enhanced with epigenomics data
14:50 ~ 17:20
Room 5 501
Symposium 5 (S5)Japanese perspectives on preclinical safety evaluation of pharmaceuticals for
pandemic infection (Learning from COVID-19 pandemic)9:20 ~ 11:20
Special Lecture 1 (SL1)Risks and Benefits of Vaccine or Nonvaccine
Therapeutic Interventions for COVID-19
Kenneth L HASTINGS11:30 ~ 12:30
Luncheon Seminar (L1-5)Charles River12:40 ~ 13:40
Symposium 10 (S10)Nonclinical safety evaluation and future perspectives of
gene therapy products14:50 ~ 16:50
Room 6 502Symposium 6 (S6)
JSOT-SOT Exchange Promotion Program: CRISPR and Opportunities for Toxicology
10:30 ~ 12:30
Luncheon Seminar (L1-6)Veritas Corporation /
Axion BioSystems12:40 ~ 13:40
Symposium 11 (S11)Reproductive and developmental toxicity in the prevention and
treatment of infectious diseases14:50 ~ 16:50
Room 7504
+505
Candidates for the Excellent Presentation Award (Oral) 1
10:30 ~ 12:00
Candidates for the Excellent Presentation Award (Oral) 2
14:50 ~ 16:14
Exhibition(On-site)
3-5F Lobby,3F Lounge,
Reception Hall
Commercial Exhibition (9:00 ~ 17:00)
Commercial Exhibition (9:00 ~ 17:00)
e-Poster/ Web Exhibition
WEB
Web Exhibition (9:00 ~ 17:00)
Web Exhibition (9:00 ~ 17:00)
e-Poster(Poster Session) e-Poster(Poster Session)
Web Seminar WEBLuncheon Seminar (LW1-1)
Ina Research. Inc.12:40 ~ 13:40
Web Seminar WEBLuncheon Seminar (LW1-2)
Elsevier Japan K.K.12:40 ~ 13:40
Web Seminar WEBLuncheon Seminar (LW1-3)
Merck Ltd.12:40 ~ 13:40
Opening Remarks9:15 ~ 9:20
〈O-1~O-3〉Oxidative stress〈O-4~O-5〉
Mechanisms of toxicity
Timetable
July 7(Wed):Day 1※e00:Pagenumber※ CM:Pleasecheckpagee106onthisProgram.
〈P-1E〉 Pharmaceutical drugs (chemicals)〈P-2E〉Agricultural chemicals〈P-33E〉Nanomaterials〈P-36E, P-37E, P-39E, P-40E〉Nervous system〈P-44E, P-48E〉Liver〈P-69E〉Reproductive system〈P-72E〉Other organs or system〈P-87E, P-89E〉Reproductive and developmental toxicology〈P-103E〉Carcinogenicity〈P-106E〉Behavioral toxicology
〈P-133E〉Cellular response〈P-139E〉Biomarkers〈P-145E, P-146E, P-149E, P-151E, P-152E〉Toxicity-testing methods〈P-154E〉Analytical method〈P-158E, P-161E, P-166E〉Alternatives to mammalian models〈P-167E〉Animal model〈P-187E〉Risk assessment and communication〈P-191E〉Information technology, AI, and big data
e22
e23
e24
e25
e51
e26
26 26
26 26
e66 e66
e99
e100
e100
e101
e29
e54
e19 e98 e29
e28
e23 e27
e27
e20
e58
e98 e19
e48 9
Room 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00
Room 1 301Symposium 1 (S1)
Toxico-epigenomics learned from a viewpoint of developmental biology and congenital anomaly 2.0
9:20 ~ 11:20
Educational Lecture 1(EL1)Immune-enhancing adjuvant for
development of safe vaccines
Tsukasa SEYA11:30 ~ 12:30
Luncheon Seminar (L1-1)SEKISUI MEDICAL CO., LTD.
12:40 ~ 13:40
Special Lecture 2 (SL2)Toward the Mysteries of Sleep
Masashi YANAGISAWA13:50 ~ 14:50
Room 2 401
CM1-
2A
Symposium 2 (S2)JALAS-JSOT Joint Symposium
9:20 ~ 11:20
Oral Session 1 (O-1 ~ O-5)
11:30 ~ 12:30
CM1-
2B
Symposium 7 (S7)Species differences and prediction of human responses withbiotherapeutics: review the monkey as a laboratory animal
14:50 ~ 16:50
Room 3 402
CM1-
3A
Symposium 3 (S3)New trends in genotoxicity research involving genome instability
9:20 ~ 11:50
Symposium 8 (S8)Risk assessments for drug-induced convulsions
14:50 ~ 16:50
Room 4 403Symposium 4 (S4)
Chemical sensing transcription factors: Toward understanding toxicity mechanism and risk assessment
9:20 ~ 11:20
Symposium 9 (S9)ToxicOmic AI analysis enhanced with epigenomics data
14:50 ~ 17:20
Room 5 501
Symposium 5 (S5)Japanese perspectives on preclinical safety evaluation of pharmaceuticals for
pandemic infection (Learning from COVID-19 pandemic)9:20 ~ 11:20
Special Lecture 1 (SL1)Risks and Benefits of Vaccine or Nonvaccine
Therapeutic Interventions for COVID-19
Kenneth L HASTINGS11:30 ~ 12:30
Luncheon Seminar (L1-5)Charles River12:40 ~ 13:40
Symposium 10 (S10)Nonclinical safety evaluation and future perspectives of
gene therapy products14:50 ~ 16:50
Room 6 502Symposium 6 (S6)
JSOT-SOT Exchange Promotion Program: CRISPR and Opportunities for Toxicology
10:30 ~ 12:30
Luncheon Seminar (L1-6)Veritas Corporation /
Axion BioSystems12:40 ~ 13:40
Symposium 11 (S11)Reproductive and developmental toxicity in the prevention and
treatment of infectious diseases14:50 ~ 16:50
Room 7504
+505
Candidates for the Excellent Presentation Award (Oral) 1
10:30 ~ 12:00
Candidates for the Excellent Presentation Award (Oral) 2
14:50 ~ 16:14
Exhibition(On-site)
3-5F Lobby,3F Lounge,
Reception Hall
Commercial Exhibition (9:00 ~ 17:00)
Commercial Exhibition (9:00 ~ 17:00)
e-Poster/ Web Exhibition
WEB
Web Exhibition (9:00 ~ 17:00)
Web Exhibition (9:00 ~ 17:00)
e-Poster(Poster Session) e-Poster(Poster Session)
Web Seminar WEBLuncheon Seminar (LW1-1)
Ina Research. Inc.12:40 ~ 13:40
Web Seminar WEBLuncheon Seminar (LW1-2)
Elsevier Japan K.K.12:40 ~ 13:40
Web Seminar WEBLuncheon Seminar (LW1-3)
Merck Ltd.12:40 ~ 13:40
Opening Remarks9:15 ~ 9:20
〈O-1~O-3〉Oxidative stress〈O-4~O-5〉
Mechanisms of toxicity
Timetable
July 7(Wed):Day 1※e00:Pagenumber※ CM:Pleasecheckpagee106onthisProgram.
〈P-1E〉 Pharmaceutical drugs (chemicals)〈P-2E〉Agricultural chemicals〈P-33E〉Nanomaterials〈P-36E, P-37E, P-39E, P-40E〉Nervous system〈P-44E, P-48E〉Liver〈P-69E〉Reproductive system〈P-72E〉Other organs or system〈P-87E, P-89E〉Reproductive and developmental toxicology〈P-103E〉Carcinogenicity〈P-106E〉Behavioral toxicology
〈P-133E〉Cellular response〈P-139E〉Biomarkers〈P-145E, P-146E, P-149E, P-151E, P-152E〉Toxicity-testing methods〈P-154E〉Analytical method〈P-158E, P-161E, P-166E〉Alternatives to mammalian models〈P-167E〉Animal model〈P-187E〉Risk assessment and communication〈P-191E〉Information technology, AI, and big data
e22
e23
e24
e25
e51
e26
26 26
26 26
e66 e66
e99
e100
e100
e101
e29
e54
e19 e98 e29
e28
e23 e27
e27
e20
e58
e98 e19
e610 11
Room 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00
Room 1 301
Special Lecture 3 (SL3)Development Challenges for Carcinogenicity
Risk Assessments of Topical DrugsBrett D HOLLINGSHEAD
9:00 ~ 10:00
Invited Lecture (IL)Kohji NISHIDA10:10 ~ 11:10
Educational Lecture 2 (EL2)ACT/JSOT: Educational Lecture
Judith PRESCOTTRobert W. AMLER
11:20 ~ 12:20
General Assembly, Award Ceremony
13:30 ~ 14:50
Award LectureThe JSOT Award
The Tetsuo Satoh AwardThe JSOT Young Scientist Award
15:10 ~ 16:40
Room 2 401Symposium 12 (S12)
AI and Informatics for the safety evaluation of chemical compounds9:00 ~ 11:30
Luncheon Seminar (L2-2)LSIM Safety Institute
Corporation12:20 ~ 13:20
Symposium 17 (S17)Latest information on safety evaluation of pesticide in the world
15:00 ~ 17:00
Room 3 402
CM2-
3A
Symposium 13 (S13)Toxicological assessment by toxicity database
using data from human ES cells/iPS cells9:00 ~ 10:30
Workshop 1 (W1)The perspective on GLP operation
in the “New Normal”10:40 ~ 12:10
Luncheon Seminar (L2-3)AS ONE CORPORATION
12:20 ~ 13:20
Symposium 18 (S18)Nephrotoxicity
- from the standpoint of clinical pharmacist and basic research -15:00 ~ 17:00
Room 4 403Symposium 14 (S14)
New insights of in vivo safety assessment strategy for drug-induced cardiac functional change
9:00 ~ 11:00
Oral Session 2 (O-6 ~ O-10)
11:10 ~ 12:10
Luncheon Seminar (L2-4)Charles River12:20 ~ 13:20
CM2-
4B
Symposium 19 (S19)Prevalence of computational toxicology for pharmaceutical:
Case study for System construction under ontology15:00 ~ 17:00
Room 5 501Symposium 15 (S15)
JSTP-JSOT Joint Symposium: Topics from the Society of Toxicological Pathology: Approach of Mode of Action for safety evaluation of chemical substances
9:00 ~ 11:30
Luncheon Seminar (L2-5)Axcelead Drug Discovery
Partners, Inc.12:20 ~ 13:20
Symposium 20 (S20)JSOT-JCA Joint Symposium:
Molecular basis and perspective for carcinogenicity assessment: human extrapolation based upon mutation signature and epigenome
15:00 ~ 17:00
Room 6 502Symposium 16 (S16)
Children’s toxicology with respect to brain function9:00 ~ 11:30
Luncheon Seminar (L2-6)Shin Nippon Biomedical
Laboratories, Ltd.12:20 ~ 13:20
Workshop 4 (W4)Collaboration Sessions:
Let’s start a communication between sponsors and PMDA15:00 ~ 17:00
Room 7504
+505
Workshop 2 (W2)New aspect of specific external
exposome study9:00 ~ 10:30
Workshop 3 (W3)Nonclinical Safety Assessment of Pharmaceuticals in 2035:
Alternatives to Animal Experiments10:40 ~ 12:10
Luncheon Seminar (L2-7)Mimetas Japan K.K. &
Molecular Devices, LLC12:20 ~ 13:20
Workshop 5 (W5)Application of novel gastrointestinal models
and biomarkers in drug development15:00 ~ 17:00
Exhibition(On-site)
3-5F Lobby,3F Lounge,
Reception Hall
Commercial Exhibition (9:00 ~ 17:00)
Commercial Exhibition (9:00 ~ 17:00)
e-Poster/ Web Exhibition
WEB
Web Exhibition (9:00 ~ 17:00)
Web Exhibition (9:00 ~ 17:00)
e-Poster(Poster Session) e-Poster(Poster Session)
Web Seminar WEBLuncheon Seminar (LW2-1)
Eurofins Discovery12:20 ~ 13:20
〈O-6 ~ O-10〉Metals
July 8(Thu):Day 2※e00:Pagenumber※ CM:Pleasecheckpagee106onthisProgram.
e19 e19
e30
e44e31
e31
e32
e33
e45
26 26
26 26
e66 e66
e44
e58
e20
e34
e35
e50
e36
e37
e46
e47
e101
e101
e102
e102
e103
e103
e104
e710 11
Room 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00
Room 1 301
Special Lecture 3 (SL3)Development Challenges for Carcinogenicity
Risk Assessments of Topical DrugsBrett D HOLLINGSHEAD
9:00 ~ 10:00
Invited Lecture (IL)Kohji NISHIDA10:10 ~ 11:10
Educational Lecture 2 (EL2)ACT/JSOT: Educational Lecture
Judith PRESCOTTRobert W. AMLER
11:20 ~ 12:20
General Assembly, Award Ceremony
13:30 ~ 14:50
Award LectureThe JSOT Award
The Tetsuo Satoh AwardThe JSOT Young Scientist Award
15:10 ~ 16:40
Room 2 401Symposium 12 (S12)
AI and Informatics for the safety evaluation of chemical compounds9:00 ~ 11:30
Luncheon Seminar (L2-2)LSIM Safety Institute
Corporation12:20 ~ 13:20
Symposium 17 (S17)Latest information on safety evaluation of pesticide in the world
15:00 ~ 17:00
Room 3 402
CM2-
3A
Symposium 13 (S13)Toxicological assessment by toxicity database
using data from human ES cells/iPS cells9:00 ~ 10:30
Workshop 1 (W1)The perspective on GLP operation
in the “New Normal”10:40 ~ 12:10
Luncheon Seminar (L2-3)AS ONE CORPORATION
12:20 ~ 13:20
Symposium 18 (S18)Nephrotoxicity
- from the standpoint of clinical pharmacist and basic research -15:00 ~ 17:00
Room 4 403Symposium 14 (S14)
New insights of in vivo safety assessment strategy for drug-induced cardiac functional change
9:00 ~ 11:00
Oral Session 2 (O-6 ~ O-10)
11:10 ~ 12:10
Luncheon Seminar (L2-4)Charles River12:20 ~ 13:20
CM2-
4B
Symposium 19 (S19)Prevalence of computational toxicology for pharmaceutical:
Case study for System construction under ontology15:00 ~ 17:00
Room 5 501Symposium 15 (S15)
JSTP-JSOT Joint Symposium: Topics from the Society of Toxicological Pathology: Approach of Mode of Action for safety evaluation of chemical substances
9:00 ~ 11:30
Luncheon Seminar (L2-5)Axcelead Drug Discovery
Partners, Inc.12:20 ~ 13:20
Symposium 20 (S20)JSOT-JCA Joint Symposium:
Molecular basis and perspective for carcinogenicity assessment: human extrapolation based upon mutation signature and epigenome
15:00 ~ 17:00
Room 6 502Symposium 16 (S16)
Children’s toxicology with respect to brain function9:00 ~ 11:30
Luncheon Seminar (L2-6)Shin Nippon Biomedical
Laboratories, Ltd.12:20 ~ 13:20
Workshop 4 (W4)Collaboration Sessions:
Let’s start a communication between sponsors and PMDA15:00 ~ 17:00
Room 7504
+505
Workshop 2 (W2)New aspect of specific external
exposome study9:00 ~ 10:30
Workshop 3 (W3)Nonclinical Safety Assessment of Pharmaceuticals in 2035:
Alternatives to Animal Experiments10:40 ~ 12:10
Luncheon Seminar (L2-7)Mimetas Japan K.K. &
Molecular Devices, LLC12:20 ~ 13:20
Workshop 5 (W5)Application of novel gastrointestinal models
and biomarkers in drug development15:00 ~ 17:00
Exhibition(On-site)
3-5F Lobby,3F Lounge,
Reception Hall
Commercial Exhibition (9:00 ~ 17:00)
Commercial Exhibition (9:00 ~ 17:00)
e-Poster/ Web Exhibition
WEB
Web Exhibition (9:00 ~ 17:00)
Web Exhibition (9:00 ~ 17:00)
e-Poster(Poster Session) e-Poster(Poster Session)
Web Seminar WEBLuncheon Seminar (LW2-1)
Eurofins Discovery12:20 ~ 13:20
〈O-6 ~ O-10〉Metals
July 8(Thu):Day 2※e00:Pagenumber※ CM:Pleasecheckpagee106onthisProgram.
e19 e19
e30
e44e31
e31
e32
e33
e45
26 26
26 26
e66 e66
e44
e58
e20
e34
e35
e50
e36
e37
e46
e47
e101
e101
e102
e102
e103
e103
e104
e812 13
Room 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00
Room 1 301Educational Lecture 3 (EL3)The Promise of Organoid Medicine
Takanori TAKEBE9:00 ~ 10:00
Educational Lecture 4 (EL4)Patient Centricity - Importance of toxicology
in pharmaceutical companiesSunao MANABE10:10 ~ 11:10
Workshop 6 (W6)Report of chemotherapyʼs
experience from toxicologists as cancer survivors13:30 ~ 14:30
Workshop 7 (W7)Science of cancer chemotherapy induced
side effects and supportive care14:40 ~ 16:40
Room 2 401Symposium 21 (S21)
ACT/JSOT Joint Session: Nonvaccine Therapeutic Interventions forCOVID-19
9:00 ~ 11:00
Educational Lecture 5 (EL5)ACT/JSOT: Educational Lecture
Stephanie Leuenroth QUINN11:10 ~ 12:10
Educational Lecture 8 (EL8)Computational toxicology and the regulatory
environment – past, present, and futureDavid R WOOLLEY
13:30 ~ 14:30
Symposium 26 (S26)Case Report
“Human Clinical Predictability of Toxicity Seen in Nonclinical studies”14:40 ~ 16:40
Room 3 402
Educational Lecture 6 (EL6)Novel defense strategy against progressive
neurodegeneration by controlling intracellular Zn2+ dysregulation
Atsushi TAKEDA9:00 ~ 10:00
Educational Lecture 7 (EL7)Covid-19, Mutations, Immune
Responses and VaccinesTatsuhiko KODAMA
10:10 ~ 11:10
Luncheon Seminar (L3-3)NIKON CORPORATION
12:20 ~ 13:20
Oral Session 3(O-11 ~ O-18)
13:30 ~ 15:06
Oral Session 4(O-19 ~ O-25)
15:10 ~ 16:34
Room 4 403Symposium 22 (S22)
Species differences in xenobiotics metabolism and detoxification9:00 ~ 11:00
CM3-
4B
Symposium 27 (S27)Safety assessment for regenerative medicine
14:00 ~ 16:00
Room 5 501Symposium 23 (S23)
Molecular basis of pathogenesis in pulmonary toxicity9:00 ~ 11:00
Luncheon Seminar (L3-5)Charles River12:20 ~ 13:20
Symposium 28 (S28)JSCT-JSOT Joint Symposium: Basic study and clinical application ofthe posioning due to inhaled drugs and/or inhalable formulations
14:00 ~ 16:00
Room 6 502
CM3-
6A
Symposium 24 (S24)JSIT-JSOT Joint Symposium: Current status and challenges for the
immunotoxicity studies of various drug modalities9:00 ~ 11:30
Luncheon Seminar (L3-6)Axcelead Drug Discovery
Partners, Inc.12:20 ~ 13:20
Symposium 29 (S29)Next Generation Research Seminar: Microbiome and Toxicology
13:30 ~ 15:30
Workshop 8 (W8)Active career of Toxicologists - You can be an AI-Powered
Toxicologist -15:40 ~ 16:40
Room 7504
+505
Symposium 25 (S25)Biometals Specialty Section Symposium
-New Development of Metallothionein Function-10:10 ~ 12:10
Luncheon Seminar (L3-7)Shin Nippon Biomedical
Laboratories, Ltd.12:20 ~ 13:20
Oral Session 5(O-26 ~ O-34)
13:30 ~ 15:18
Oral Session 6(O-35 ~ O-41)
15:20 ~ 16:44
Exhibition(On-site)
3-5F Lobby,3F Lounge,
Reception Hall
Commercial Exhibition (9:00 ~ 14:00)
Commercial Exhibition (9:00 ~ 14:00)
e-Poster/Web Exhibition
WEB
Web Exhibition (9:00 ~ 17:00)
Web Exhibition(9:00 ~ 17:00)
e-Poster(Poster Session) e-Poster(Poster Session)
Closing Remarks
16:40 ~ 16:55
〈O-11~O-15〉Environmental pollutants〈O-16〉Nanomaterials〈O-17〉Environmental pollutants〈O-18〉Nanomaterials
〈O-19〉General toxicology〈O-20〉Behavioral toxicology〈O-21〉Immunotoxicology〈O-22~O-23〉Epigenetics〈O-24〉Toxicity-testing methods〈O-25〉Alternatives to mammalian models
〈O-26~O-28〉Nervous system〈O-29〉Cardiovascular system〈O-30〉Kidney〈O-31~O-32〉Liver〈O-33〉Information technology, AI, and big data〈O-34〉AOP (adverse outcome pathway)
〈O-35〉Reproductive system〈O-36~O-41〉Reproductive and developmental toxicology
July 9(Fri):Day 3※ e00:Page number※ CM:Please check page e106 on this Program.
e105
e105
e20
e37
e21
e38
e38
e39
e40
26
26
e66
e21
e21
e20
26
26
e66
e47 e48
e21
e59
e43 e49
e42
e42
e64e62
e61
e41
e104
e104
e912 13
Room 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00
Room 1 301Educational Lecture 3 (EL3)The Promise of Organoid Medicine
Takanori TAKEBE9:00 ~ 10:00
Educational Lecture 4 (EL4)Patient Centricity - Importance of toxicology
in pharmaceutical companiesSunao MANABE10:10 ~ 11:10
Workshop 6 (W6)Report of chemotherapyʼs
experience from toxicologists as cancer survivors13:30 ~ 14:30
Workshop 7 (W7)Science of cancer chemotherapy induced
side effects and supportive care14:40 ~ 16:40
Room 2 401Symposium 21 (S21)
ACT/JSOT Joint Session: Nonvaccine Therapeutic Interventions forCOVID-19
9:00 ~ 11:00
Educational Lecture 5 (EL5)ACT/JSOT: Educational Lecture
Stephanie Leuenroth QUINN11:10 ~ 12:10
Educational Lecture 8 (EL8)Computational toxicology and the regulatory
environment – past, present, and futureDavid R WOOLLEY
13:30 ~ 14:30
Symposium 26 (S26)Case Report
“Human Clinical Predictability of Toxicity Seen in Nonclinical studies”14:40 ~ 16:40
Room 3 402
Educational Lecture 6 (EL6)Novel defense strategy against progressive
neurodegeneration by controlling intracellular Zn2+ dysregulation
Atsushi TAKEDA9:00 ~ 10:00
Educational Lecture 7 (EL7)Covid-19, Mutations, Immune
Responses and VaccinesTatsuhiko KODAMA
10:10 ~ 11:10
Luncheon Seminar (L3-3)NIKON CORPORATION
12:20 ~ 13:20
Oral Session 3 (O-11 ~ O-18)
13:30 ~ 15:06
Oral Session 4 (O-19 ~ O-25)
15:10 ~ 16:34
Room 4 403Symposium 22 (S22)
Species differences in xenobiotics metabolism and detoxification9:00 ~ 11:00
CM3-
4B
Symposium 27 (S27)Safety assessment for regenerative medicine
14:00 ~ 16:00
Room 5 501Symposium 23 (S23)
Molecular basis of pathogenesis in pulmonary toxicity9:00 ~ 11:00
Luncheon Seminar (L3-5)Charles River12:20 ~ 13:20
Symposium 28 (S28)JSCT-JSOT Joint Symposium: Basic study and clinical application ofthe posioning due to inhaled drugs and/or inhalable formulations
14:00 ~ 16:00
Room 6 502
CM3-
6A
Symposium 24 (S24)JSIT-JSOT Joint Symposium: Current status and challenges for the
immunotoxicity studies of various drug modalities9:00 ~ 11:30
Luncheon Seminar (L3-6)Axcelead Drug Discovery
Partners, Inc.12:20 ~ 13:20
Symposium 29 (S29)Next Generation Research Seminar: Microbiome and Toxicology
13:30 ~ 15:30
Workshop 8 (W8)Active career of Toxicologists - You can be an AI-Powered
Toxicologist -15:40 ~ 16:40
Room 7504
+505
Symposium 25 (S25)Biometals Specialty Section Symposium
-New Development of Metallothionein Function-10:10 ~ 12:10
Luncheon Seminar (L3-7)Shin Nippon Biomedical
Laboratories, Ltd.12:20 ~ 13:20
Oral Session 5 (O-26 ~ O-34)
13:30 ~ 15:18
Oral Session 6 (O-35 ~ O-41)
15:20 ~ 16:44
Exhibition(On-site)
3-5F Lobby,3F Lounge,
Reception Hall
Commercial Exhibition (9:00 ~ 14:00)
Commercial Exhibition (9:00 ~ 14:00)
e-Poster/Web Exhibition
WEB
Web Exhibition(9:00 ~ 17:00)
Web Exhibition (9:00 ~ 17:00)
e-Poster(Poster Session) e-Poster(Poster Session)
Closing Remarks
16:40 ~ 16:55
〈O-11~O-15〉Environmental pollutants〈O-16〉Nanomaterials〈O-17〉Environmental pollutants〈O-18〉Nanomaterials
〈O-19〉General toxicology〈O-20〉Behavioral toxicology〈O-21〉Immunotoxicology〈O-22~O-23〉Epigenetics〈O-24〉Toxicity-testing methods〈O-25〉Alternatives to mammalian models
〈O-26~O-28〉Nervous system〈O-29〉Cardiovascular system〈O-30〉Kidney〈O-31~O-32〉Liver〈O-33〉Information technology, AI, and big data〈O-34〉AOP (adverse outcome pathway)
〈O-35〉Reproductive system〈O-36~O-41〉Reproductive and developmental toxicology
July 9(Fri):Day 3※ e00:Pagenumber※ CM:Pleasecheckpagee106onthisProgram.
e105
e105
e20
e37
e21
e38
e38
e39
e40
26
26
e66
e21
e21
e20
26
26
e66
e47 e48
e21
e59
e43 e49
e42
e42
e64e62
e61
e41
e104
e104